IL15 and neoplasm: CISH−/− iNK cells expand and display in vitro short-term and long-term cytotoxicity, IFN-γ production and degranulation capacity against multiple tumor targets (K562, MOLM and SKOV3 cells) at IL-15- or IL-2-limiting conditions.